Marseille,
cradle of immunotherapy

MIB's 10-year scientific objectives

1

Blockbuster approved

3

Approved niche antibodies

5

Phase 2/3 antibodies

MIB's 10-year scientific objectives

30

New viable startups

30

Implantations d’entreprises

Phase 1/2 trials in immunology
+ 0 %
Direct job creation
+ 0 K
Billions of euros in capital
+ 0 MDS

We are present at

Paris
Marseille
Brest
Montpellier